EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

Predictors of P2Y12 Inhibitor Selection in Patients with Acute Coronary Syndrome: The Role of Age and Baseline aPTT Values

Delia Isfani, Rangki Astiani, ⁠Tashya Dhela Maylinda

JURNAL FARMASIMED (JFM) · 30.10.2026 · 9 (1) · 49-58

DOI: 10.35451/69snqx87 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JURNAL FARMASIMED (JFM), online erschienen am 30.10.2026. Verfasst von Delia Isfani und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although international guidelines strongly recommend potent P2Y12 inhibitors (ticagrelor) for acute coronary syndrome (ACS) patients, real-world clinical adherence frequently deviates, creating a distinct evidence-practice gap, particularly in developing nations.

Aim

This retrospective cross-sectional study aimed to evaluate sociodemographic and laboratory predictors influencing the selection of dual antiplatelet therapy (clopidogrel versus ticagrelor) among 254 ACS patients at a tertiary hospital in Jakarta from January to December 2025.

Methode

Data were extracted from medical records and analyzed using multivariate binary logistic regression.

Result

The results demonstrated that the vast majority of the cohort (83.8%, n=213) received an aspirin-clopidogrel combination, whereas only 16.1% (n=41) were initiated on ticagrelor. Multivariate analysis identified age and baseline activated partial thromboplastin time (aPTT) as significant independent predictors of therapy selection, specifically revealing that advancing age (aOR 0.946; 95% CI: 0.910–0.983; p=0.005) and prolonged baseline aPTT (aOR 0.854; 95% CI: 0.763–0.992; p=0.039) substantially reduced the probability of ticagrelor prescription. These findings establish that advanced age and prolonged baseline aPTT operate as independent determinants driving clinicians to de-escalate P2Y12 therapy to clopidogrel.

Conclusion

This highlights the application of a heuristic approach in real-world clinical practice, where mitigating bleeding risk in vulnerable demographics is systematically prioritized over maximizing the efficacy of potent anti-ischemic agents.

Zitieren

APA

Isfani, D., Astiani, R., & Maylinda, T. D. (2026). Predictors of P2Y12 Inhibitor Selection in Patients with Acute Coronary Syndrome: The Role of Age and Baseline aPTT Values. JURNAL FARMASIMED (JFM), 9(1), 49-58. https://doi.org/10.35451/69snqx87

Vancouver

Isfani D, Astiani R, Maylinda TD. Predictors of P2Y12 Inhibitor Selection in Patients with Acute Coronary Syndrome: The Role of Age and Baseline aPTT Values. JURNAL FARMASIMED (JFM). 2026;9(1):49-58. doi:10.35451/69snqx87

BibTeX
@article{Isfani2026,
  author = {Isfani, Delia and Astiani, Rangki and Maylinda, ⁠Tashya Dhela},
  title = {Predictors of P2Y12 Inhibitor Selection in Patients with Acute Coronary Syndrome: The Role of Age and Baseline aPTT Values},
  journal = {JURNAL FARMASIMED (JFM)},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {49--58},
  doi = {10.35451/69snqx87}
}
Kostenlos starten →